Benefit and risk of early intravenous heparin after thrombolysis in patients with acute ischemic stroke.

Document Type

Article

Abstract

BACKGROUND AND PURPOSE: We performed a retrospective analysis of the "Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China)" registry to explore the benefit and risk of intravenous thrombolysis (IVT) followed by intravenous heparin (IVH) in acute ischemic stroke (AIS) patients.

METHODS: In the TIMS-China database, the patients who received IVH immediately after IVT (Early IVH group) and those who initiated antithrombotic therapy (ATT) until 24 hr after IVT (Standard ATT group) were screened for this comparison. Propensity score (PS) matching was performed between both groups. The logistic regression analysis was performed in the matched population to compare all the efficacy and safety outcomes.

RESULTS: Of 1,437 patients in this study, 119 received early IVH and 1,318 cases initiated standard ATT. After PS matching (1:2), 117 pairs were identified. The early IVH group had higher proportions of neurological improvement at 24 hr (OR = 2.24, 95% CI = 1.42-3.53) and 7 days (OR = 1.92, 95% CI = 1.22-3.03), better chance of excellent recovery (OR = 1.69, 95% CI = 1.07-2.67) and functional independence (OR = 1.77, 95% CI = 1.13-2.78) at 90 days, and a lower 90-day mortality (OR = 0.44, 95% CI = 0.21-0.92) than standard ATT group. Additionally, early IVH did not increase the risk of symptomatic intracranial hemorrhage (OR = 0.92, 95% CI = 0.34-2.48).

CONCLUSIONS: IVH immediately after thrombolysis seems to be safe and potentially more effective as compared with standard ATT delay of 24 hr for a subset of AIS patients.

Medical Subject Headings

Brain Ischemia; China; Fibrinolytic Agents; Heparin; Humans; Ischemic Stroke; Retrospective Studies; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome

Publication Date

10-1-2020

Publication Title

Brain Behav

ISSN

2162-3279

Volume

10

Issue

10

First Page

01776

Last Page

01776

PubMed ID

32892463

Digital Object Identifier (DOI)

10.1002/brb3.1776

This document is currently not available here.

Share

COinS